Einzelne Wirkstoffpartikel sorgen für ein sanftes, angenehmes Mundgefühl, ohne Nachgeschmack
Mikroverkapselung durch Koazervation:
- Gleichmässige Beschichtung eines festen Teilchens oder eines Flüssigkeitstropfens mit einem starren, halbdurchlässigen Polymer
- Schafft eine physische Barriere
- Wirksame Maskierung des Geschmacks
- Individuelles Freigabeprofil
- Nicht wässrige Flüssigkeiten in Pulver verwandeln
- Kombinieren Sie inkompatible APIs
Die endgültigen Darreichungsformen können in hergestellt werden:
- Pulver
- Trockene Sirupe
- Mündlich zerfallende Tabletten
- Parvulet® Darreichungsform: weiche, lebensmittelähnliche Textur
Sprechen Sie mit einem Experten
Srinivasan Shanmugam, Ph.D.
Leitender Direktor, Pharmazeutische Wissenschaften, Business Support und neue Technologien
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.
